Quantcast
Home » Topics » Medicines

Licensing deal to boost HIV drug access

US pharmaceutical giant Gilead Sciences and an NGO called the Medicines Patent Pool announced a deal on Tuesday aimed at boosting access to HIV drugs in poorer countries through generic manufacturing. The HIV medicines tenofovir and emtricitabine, as well as two drugs that are still in clinical development, cobicistat and…

Google+